Search for: "Actavis Pharma"
Results 61 - 80
of 243
Sort by Relevance
|
Sort by Date
5 Apr 2016, 6:32 am
Big pharma will never want to sue a doctor for prescribing the product to a patient. [read post]
5 Apr 2016, 2:12 am
Actavis, Inc., 133 S. [read post]
22 Mar 2016, 4:00 am
Although manufacturers are still fragmented, consolidations continue based on “better rationales” (given the standard merger rewards may not necessarily exist): including Pfizer/Hospira, Teva/Actavis and focused start-ups. [read post]
21 Feb 2016, 8:07 pm
Actavis Laboratories UT, Inc. v. [read post]
20 Jan 2016, 7:50 am
Sleet in Tris Pharma v. [read post]
15 Nov 2015, 9:32 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
5 Nov 2015, 9:39 pm
Actavis Laboratories FL, Inc. 1:15-cv-00686; filed August 5, 2015 in the District Court of Delaware • Plaintiffs: Purdue Pharma L.P.; Purdue Pharmaceuticals L.P.; The P.F. [read post]
12 Oct 2015, 12:11 pm
| IP: When innovation is the answer to a spiritual funk Never Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s… [read post]
5 Oct 2015, 5:13 am
| IP: When innovation is the answer to a spiritual funkNever Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v… [read post]
28 Sep 2015, 3:35 am
| IP: When innovation is the answer to a spiritual funkNever Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v… [read post]
25 Sep 2015, 8:17 am
Chem/pharma: no explosion, not much failure to bargain. [read post]
20 Sep 2015, 4:08 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v… [read post]
15 Sep 2015, 1:39 am
This is a tale of the evaluation of ‘expectation of success’ as part of inventive step analysis having gone wrong in a pharma setting. [read post]
13 Sep 2015, 9:21 pm
• Defendants: Watson Laboratories, Inc.; Actavis, Inc.; Actavis Pharma, Inc. [read post]
7 Sep 2015, 10:01 am
When Purdue Pharma introduced OxyContin in 1996, it was aggressively marketed and highly promoted. [read post]
3 Aug 2015, 5:10 am
Pick one of those and it will surely work (albeit it would be a mere arbitrary, non-inventive selection of the type discussed in Actavis v Novartis [2010]). [read post]
7 Jul 2015, 1:58 am
China-watcher and a former occasional contributor to this weblog Tom Carver leads the session on enforcing pharma patents in that vast, imponderable jurisdiction. [read post]
3 Jun 2015, 9:55 am
Actavis, Inc., 133 S. [read post]
31 May 2015, 9:59 pm
• Defendants: Actavis Laboratories FL Inc.; Andrx Corp.; Actavis Inc.; Actavis Pharma Inc. [read post]
31 May 2015, 3:47 am
Bio and pharma patent attorneys have had an entertaining few months following the exploits of Swiss-style claims in the Courts of England and Wales. [read post]
